Search

Your search keyword '"Sánchez-Cantalejo, Emilio"' showing total 181 results

Search Constraints

Start Over You searched for: Author "Sánchez-Cantalejo, Emilio" Remove constraint Author: "Sánchez-Cantalejo, Emilio"
181 results on '"Sánchez-Cantalejo, Emilio"'

Search Results

1. General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition

3. Plasma levels of OPN (ng/ml) in HCC Cases and matched Controls. from Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population

4. Data from Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population

5. Supplementary Figures Legends from Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population

6. Cubic spline for the association between OPN levels and HCC from Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population

7. Supplementary Tables from Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population

8. An epidemiological model for prediction of endometrial cancer risk in Europe

12. Dietary intake of acrylamide and esophageal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort

14. Hepcidin levels and gastric cancer risk in the EPIC-EurGast study

15. Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

17. Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

18. Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)

19. Lifestyle factors and mortality risk in individuals with diabetes mellitus: are the associations different from those in individuals without diabetes?

20. Total, caffeinated and decaffeinated coffee and tea intake and gastric cancer risk: Results from the EPIC cohort study

21. Variation at ABO histo-blood group and FUT loci and diffuse and intestinal gastric cancer risk in a European population

22. Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: Results from the EPIC-EURGAST study

25. Aromatic adducts and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Spanish cohort

27. Polymorphisms of Helicobacter pylori signaling pathway genes and gastric cancer risk in the European prospective investigation into cancer-eurgast cohort

29. Fruit and vegetable intake and the risk of gastric adenocarcinoma: A reanalysis of the european prospective investigation into cancer and nutrition (EPIC-EURGAST) study after a longer follow-up

30. Genetic variation in alcohol dehydrogenase (ADH1A, ADH1B, ADH1C, ADH7) and aldehyde dehydrogenase (ALDH2), alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

32. Pre-hospital antibiotic treatment and mortality caused by invasive meningococcal disease, adjusting for indication bias

33. Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort

34. Blood Metabolic Signatures of Body Mass Index: A Targeted Metabolomics Study in the EPIC Cohort

35. Aromatic DNA adducts and breast cancer risk: a case-cohort study within the EPIC-Spain

36. Endometrial cancer risk prediction including serum-based biomarkers: results from the EPIC cohort

37. A method for sensitivity analysis to assess the effects of measurement error in multiple exposure variables using external validation data

38. Use of Two-Part Regression Calibration Model to Correct for Measurement Error in Episodically Consumed Foods in a Single-Replicate Study Design: EPIC Case Study

39. Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population

40. Diet Quality Scores and Prediction of All-Cause, Cardiovascular and Cancer Mortality in a Pan-European Cohort Study

41. Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study

42. Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case–Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort

43. Life-course social position, obesity and diabetes risk in the EPIC-Spain Cohort

44. An epidemiological model for prediction of endometrial cancer risk in Europe

45. Adipose tissue concentrations of persistent organic pollutants and total cancer risk in an adult cohort from Southern Spain: Preliminary data from year 9 of the follow-up

46. Factores asociados al uso de la vía pulmonar e intravenosa en una muestra de consumidores de heroína en Granada

47. Total, caffeinated and decaffeinated coffee and tea intake and gastric cancer risk: Results from the EPIC cohort study

48. Variation atABOhisto-blood group andFUTloci and diffuse and intestinal gastric cancer risk in a European population

49. Aromatic adducts and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Spanish cohort

50. Genetic association of gastric cancer with miRNA clusters including the cancer-related genesMIR29, MIR25, MIR93andMIR106: Results from the EPIC-EURGAST study

Catalog

Books, media, physical & digital resources